National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

saquinavir mesylate
The mesylate salt form of saquinavir, a synthetic peptidomimetic substrate with antiviral property. Saquinavir selectively binds to and inhibits human immunodeficiency virus type 1 (HIV-1) protease, an aspartic protease that cleaves viral gag and gag-pol polyprotein (precursors for viral proteases, reverse transcriptase, and integrase). Inhibition of HIV-1 protease prevents functional viral proteins to be cleaved from the viral polyprotein precursor and results in the release of immature, noninfectious virions. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Invirase



Previous:Sandostatin pamoate, Sandostatin pamoate LAR, SangCya, sapacitabine, saponin-cholesterol-phospholipid adjuvant
Next:Sarasar, SarCNU, sargramostim, sargramostim plasmid DNA hepatocellular carcinoma vaccine adjuvant, sargramostim plasmid DNA melanoma vaccine adjuvant

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov